Document is current
Any future updates will be listed below
-
Authors
Stienstra, Cailum M. K. https://orcid.org/0000-0001-7365-1558
Song, Jaegun
Healey, David https://orcid.org/0000-0002-9584-9757
Voronov, Gennady
Gardner, Eric
Patel, Abhishek
Macherla, Venkat
Krettler, Christoph A. https://orcid.org/0000-0002-5709-3864
Kind, Tobias
Dorrestein, Pieter C. https://orcid.org/0000-0002-3003-1030
Domingo-Fernández, Daniel https://orcid.org/0000-0002-2046-6145
- License Information
-
More Information
Article History
Received: 2 October 2025
Accepted: 28 November 2025
First Online: 17 December 2025
Competing interests
: P.C.D. is an advisor and holds equity in Cybele, BileOmix, Sirenas, and a scientific co-founder, advisor, holds equity and/or received income from Ometa, Enveda, and Arome with prior approval by UC San Diego. P.C.D. also consulted for DSM animal health in 2023. All other authors were employees of Enveda Therapeutics Inc. during the course of this work and have a real or potential ownership interest in the company.
